Europe — EMA
Paclitaxel Pliva
Paclitaxel, the active ingredient in Paclitaxel Pliva, is a chemotherapy agent presented as a sterile injectable solution for intravenous use. It treats various solid tumours and is administered in oncology centres.
Request sourcing
What is Paclitaxel?
Paclitaxel, the active ingredient in Paclitaxel Pliva, is a chemotherapy agent presented as a sterile injectable solution for intravenous use. It treats various solid tumours and is administered in oncology centres. GNH USA supplies Paclitaxel Pliva as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres worldwide.
GNH USA supplies Paclitaxel Pliva as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres worldwide.
What is Paclitaxel used for?
Paclitaxel Pliva is used primarily for solid tumours that belong to the following pathways or disease family:
- Breast breast cancer: Achieves the reduction of tumour size and growth in patients with advanced disease. - Ovarian ov…
What are the side effects of Paclitaxel?
Common ...
What precautions apply to Paclitaxel?
…
What does Paclitaxel interact with?
…
Product details
Related products
Paclitaxel 100 mg/20mL
Paclitaxel · 100 mg/20 mL
PACLITAXEL PROTEIN BOUND PARTICLES ALBUMIN BOUND 100 mg/20mL
Paclitaxel · 100 mg/20 mL
Paclitaxel 6 mg/mL
Paclitaxel · 6 mg/mL
Paclitaxel 6 mg/mL
Paclitaxel · 6 mg/mL